natalie_douglas

Healthcare at Home names interim chief

pharmafile | June 13, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing healthcare at home, natalie douglas 

Clinical services firm Healthcare at Home has appointed Natalie Douglas as interim chief executive, as Mike Gordon becomes non-executive chairman. 

Douglas (pictured) has two decades experience in the pharma and healthcare sector and is the former chief executive of Idis, a UK-based healthcare service business.

She is currently a non-executive director of Swiss-based firm Shield Therapeutics, and a non-executive director of California-based The Global Genes/RARE Project, a rare and genetic disease non-profit organisation.

Advertisement

Douglas says: “I’ve known and respected Healthcare at Home for many years as an organisation making treatment in the comfort of people’s homes a reality for hundreds of thousands of people. I am pleased to have been given this opportunity and responsibility to lead the business at this time and, in particular, to rebuild the company’s operational capability.”

Healthcare at Home notes it would like to thank Mike Gordon for his substantial contribution to establishing the company.

 

Related Content

No items found
The Gateway to Local Adoption Series

Latest content